Vascular access type and risk of mortality in a national prospective cohort of haemodialysis patients

QJM: An International Journal of Medicine

Volumn 105, Issue 11, 2012, Pages 1097-1103

  Bray, B D ^a   Boyd, J ^b   Daly, C ^a   Donaldson, K ^c   Doyle, A ^d   Fox, J G ^a   Innes, A ^e   Khan, I ^f   Peel, R K ^g   Severn, A ^h   Shilliday, I ⁱ   Simpson, K ^a   Stewart, G A ^h   Traynor, J ⁱ   Metcalfe, W ^j  

^a Glasgow Renal and Transplant Unit   (United Kingdom)

^b Information Services Division Scotland   (United Kingdom)

^c DUMFRIES AND GALLOWAY ROYAL INFIRMARY   (United Kingdom)

^d QUEEN MARGARET HOSPITAL   (United Kingdom)

^e CROSSHOUSE HOSPITAL   (United Kingdom)

^f ABERDEEN ROYAL INFIRMARY   (United Kingdom)

^g RAIGMORE HOSPITAL   (United Kingdom)

^h NINEWELLS HOSPITAL   (United Kingdom)

ⁱ MONKLANDS HOSPITAL   (United Kingdom)

^j ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84868031793     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcs143     Document Type: Article

References (29)

1. UK Renal Registry. 13th Annual Report. UK Renal Registry. 2011.
2. Information Services Division, National Health Service for Scotland. 2010 Scottish Renal Registry Report, 2011.
3. Go A, Chertow G, Fan D, McCulloch CE, Hsu C. Chronic kidney disease and the risk of deaths, cardiovascular events, and hospitalization. N Engl J Med 2004; 351:1296-305.
4. Khan IH, Catto GRD, MacLeod AM, Edward N, Fleming LE. Influence of coexisting disease on survival on renalreplacement therapy. Lancet 1993; 8842:415-18.
5. Metcalfe W, Khan IH, Prescott GJ, Simpson K, MacLeod AM. End-stage renal disease in Scotland: outcomes and standards of care. Kidney Int 2003; 64:1808-16.
6. Caskey FJ, Roderick P, Steenkamp R, Nitsch D, Thomas K, Annsell D, et al. Social deprivation and survival on renal replacement therapy in England and Wales. Kidney Int 2006; 70:2134-40.
7. Thomson PC, Stirling CM, Geddes CC, Morris ST, Mactier RA. Vascular access in haemodialysis patients: a modifiable risk factor for bacteraemia and death. QJM 2007; 100:415-22.
8. Rayner HC, Pisoni RL. The increasing use of haemodialysis catheters: evidence from the DOPPS on its significance and ways to reverse it. Semin Dial 2010; 23:6-10.
9. National Kidney Foundation. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations: 2006 Updates: Vascular Access. [http://www.kidney.org/ Professionals/kdoqi/guideline_upHD_PD_VA/va_guide1.htm] Accessed 29 July 2012.
10. Renal Association. Vascular Access for Haemodialysis Clinical Guideline. [http://www.renal.org/Clinical/GuidelinesSection/VascularAccess.aspx]. Accessed 29 July 2012.
11. Pastan S, Soucie M, McClellan WM. Vascular access and increased risk of death among haemodialysis patients. Kidney Int 2002; 62:620-6.
12. Moist LM, Trpeski L, Na Y, Lok CE. Associated mortality risk: data from the Canadian Organ Replacement Registry 2001-2004. Clin J Am Soc Nephrol 2008; 3:1726-32.
13. Dhingra RK, Young EW, Hulbert-Shearon TE, Leavey SF, Port FK. Type of vascular access and mortality in US haemodialysis patients. Kidney Int 2001; 60:1443-51.
14. Pisoni RL, Arrington CJ, Albert JM, Ethier J, Kimata N, Krishnan M, et al. Facility haemodialysis vascular access use and mortality in countries participating in DOPPS: an instrumental variable analysis. Am J Kid Dis 2009; 53:475-91.
15. Astor BC, Eustace JA, Powe NR, Klag MJ, Coresh J. Type of vascular access and survival among incident haemodialysis patients: the choices for healthy outcomes in caring for ESRD (CHOICE) study. J Am Soc Nephrol 2005; 16:1449-55.
16. Polkinghorne KR, McDonald SP, Atkins RC, Kerr PG. Vascular access and all-cause mortality: a propensity score analysis. J Am Soc Nephrol 2004; 15:477-86.
17. Xue JL, Dahl D, Ebben J, Collins AJ. The association of initial haemodialysis access type with mortality outcomes in elderly medicare ESRD patients. Am J Kidney Dis 2003; 42:1013-9.
18. Scottish Renal Registry. [http://www.srr.scot.nhs.uk/Projects/ methods.html] Accessed August 2011.
19. Allon M, Daugirdas J, Depner TA, Greene T, Ornt D, Schwab SJ. Effect of change in vascular access on patient mortality in haemodialysis patients. Am J Kid Dis 2006; 47:469-77.
20. Winkelmayer WG, Owen WF, Levin R, Avorn J. A propensity analysis of late versus early nephrologist referral and mortality on dialysis. J Am Soc Nephrol 2003; 14:486-92.
21. Schwenger V, Morath C, Hofmann A, Hoffman O, Zeier M, Ritz E. Late-referral-a major cause of poor outcome in the very elderly dialysis patient. NDT 2006; 21:962-7.
22. Wasse H, Speckman RA, McClellan WM. Arteriovenous fistula use is associated with lower cardiovascular mortality compared with catheter use among ESRD patients. Semin Dial 2008; 21:483-9.
23. Lukowsky LR, Kheifets L, Arah OA, Nissenson AR, Kalantar-Zadeh H. Patterns and predictors of early mortality in incident haemodialysis patients: new insights. Am J Nephrol 2012; 35:548-58.
24. Lok CE, Morzycki MH. Prevention and management of catheter-related infection in haemodialysis patients. Kidney Int 2011; 79: 587-98.
25. Ishani A, Collins AJ, Herzog CA, Foley RN. Septicaemia, access and cardiovascular disease in dialysis patients: the USRDS wave 2 study. Kidney Int 2005; 68:311-8.
26. Scottish Patient Safety Program, NHS Scotland. [http://www.patientsafetyalliance.scot.nhs.uk/programme] Accessed 29 July 2012.
27. AV Fistula First: AV Fistula First Breakthrough Coalition, Arteriovenous Fistula First. [http://www.fistulafirst.org] Accessed 29 July 2012.
28. Confirmation of Payment by Results Arrangements for 2010-2011. London, England, Department of Health. [http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_112284] Accessed 29 July 2012.
29. Santoro A, Canova C, Freyrie A, Mancini E. Vascular access for haemodialysis. J Nephrol 2006; 19:259-64.